NCT04853693

Brief Summary

The project is aimed at children who are exposed to the toxic psychosocial stress present in their mothers during pregnancy or after childbirth. Due to psychosocial stress in their mothers, these children are at risk of developing a mental disorder or having impaired psychosocial development. In Czechia, there is no prevention of psychosocial stress in women, which also plays a preventive role in the development of mental disorders in their children. Mental disorders in parents are stigmatized in Czechia, which prevents parents from seeking care. The investigators want to change this situation, so they will:

  1. 1.create and pilot a screening program for psychosocial stress in perinatal women in gynecological clinics
  2. 2.connect the screening program to the integrated step care system created by the investigators, including peer support, which the investigators will test

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2021

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

April 8, 2021

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 21, 2021

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2023

Completed
Last Updated

April 11, 2022

Status Verified

April 1, 2022

Enrollment Period

2 years

First QC Date

April 8, 2021

Last Update Submit

April 8, 2022

Conditions

Outcome Measures

Primary Outcomes (3)

  • Treatment gap for postpartum mental disorders

    prevalence of untreated mental health disorders in postpartum women assessed by The Mini-International Neuropsychiatric Interview

    6 weeks postpartum

  • Pregnancy depressive symptoms

    self-rated depressive symptomatology measured by Edinburgh Postnatal Depression Scale. Score range 0-30, higher score represents worse outcome.

    up to 32 weeks

  • Postpartum depressive symptoms

    self-rated depressive symptomatology measured by Edinburgh Postnatal Depression Scale. Score range 0-30, higher score represents worse outcome.

    6 weeks postpartum

Secondary Outcomes (2)

  • Pregnancy anxiety symptoms

    up to 32 weeks

  • Postpartum anxiety symptoms

    6 weeks postpartum

Other Outcomes (3)

  • Psychosocial stress factors

    through study completion, an average of 1 year

  • Prenatal mother-baby attachment

    up to 32 weeks

  • Parenting competences

    6 weeks postpartum

Study Arms (2)

Mom´s Supporting Mom (MSM)

EXPERIMENTAL

A preventive intervention that involves psychoeducation and peer techniques described in study detailed description.

Behavioral: Mom´s Supporting Mom

Enhanced Treatment as Usual

ACTIVE COMPARATOR

Referral to treatment in the community and monitoring

Behavioral: Enhanced Treatment As Usual

Interventions

A preventive peer consultation intervention for Postpartum Depression.

Also known as: MSM
Mom´s Supporting Mom (MSM)

Referral to treatment in the community, clinical monitoring

Also known as: ETAU
Enhanced Treatment as Usual

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • sex-female
  • pregnancy
  • woman is registered during and after pregnancy in one of 20 study gynecological outpatient clinics
  • signing informed consent
  • email address ownership
  • age 18-45
  • Edinburgh Postpartum Depression Scale score ≥10.
  • participant identified through the ACTIVITY 1 of the study

You may not qualify if:

  • \- acute medical illness or significant pregnancy complication (based on self-report)
  • acute suicidal behavior (based on self-report)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institute of Mental Health

Klecany, 25067, Czechia

RECRUITING

Related Publications (1)

  • Horakova A, Kuklova M, Hrdlickova K, Nemcova H, Knytl P, Kostylkova L, Sebela A. Effectiveness of the mom supports mom peer support intervention in treating antenatal mental health difficulties in women. Midwifery. 2024 Dec;139:104198. doi: 10.1016/j.midw.2024.104198. Epub 2024 Sep 24.

MeSH Terms

Conditions

DepressionAnxiety DisordersDepression, Postpartum

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorMental DisordersPuerperal DisordersPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDepressive DisorderMood Disorders

Study Officials

  • Antonin Sebela, Ph.D.

    National Institute of Mental Health, Klecany, Czechia

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Pavla Spadova, Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The investigator and person administering the outcome measures are blind to participant group
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Two groups: One receives MSM prevention intervention and the other group receives Enhanced Treatment as Usual (referral and monitoring).
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 8, 2021

First Posted

April 21, 2021

Study Start

April 1, 2021

Primary Completion

March 31, 2023

Study Completion

March 31, 2023

Last Updated

April 11, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will share

De-identified data may be made available to other researchers.

Shared Documents
ICF
Time Frame
After the completion of the study
Access Criteria
Permission of the PI

Locations